Clinical Trial Update: ATG-010(Selinexor) in Combination With Chemotherapy in RRMM [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for ATG-010 (Selinexor) combined with chemotherapy in relapsed refractory multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• ATG-010

Snippet

Sponsor: Chunyan Sun, MD | Conditions: Multiple Myeloma | Phase 2 | Status: UNKNOWN